|
柒、參考文獻 Baert, L., Vermeersch, H., Remon, J.P., Smeyers-Verbeke, J. and Massart, D.L., Study of parameters important in the spheronization process. International Journal of Pharmaceutics., 1993 ; 96 : 225-229. Bataille, B., Lizarski, K., Jacob, M., Thomas, C. and Duru, C., Study of the influence of spheronization and drying conditions on the physico-mechanical properties of neutral spheroids containing Avicel PH101 and lactose. Drug Development and Industrial Pharmacy., 1993 ; 19 : 653-671 Bennett, J. P., Free radical, oxidative stress and the origin Parkinson’s disease., Journal of the Neurological Sciences., 1999 ; 170 : 75-76. Kim, S. H., Kaminker, P., Campisi, J., Telomeres, aging and cancer : In search of a happy ending., Oncogene., 2002 ; 21 : 503-511. Bordea, A. and Leucuta, S.E., Optimization of propranolol hydrochloride sustained release pellets using a factorial design. International Journal of Pharmaceutics., 1997 ; 154 : 49-57. Bullock, R., New durgs for Alzheimer’s disease and other dementias., British Journal of Psychiatry., 2002 ; 180 :135-139. Butterfield, D. A., Howard, B., Yatin, S., Koppal, T., Drake, J., Hensley, K., Aksenov, M., Aksenova, M., Subramaniamm, R., Varadarajan, S., Harris-White, M. E., Pedigo, Jr. W., Carney, M., Elevated oxidative stress in models of normal brain aging and alzheimer’s disease. Life Science., 1999 ; 65 : 1883-1892. Cameron, I., Curran, S., Newton, P. et al., Use of donepezil for the treatment of mild-moderate Alzheimer’s disease : an audit of the assessment and treatment of patients in routine clinical practice. International Journal of Geriatric Psychiatry. 2000 ; 15 : 887-891. Christen, Y., Oxideative stress and Alzheimer’s disease. American Journal of Clinical Nutrition., 2000 ; 71(suppl) : 621S-629S. Corey-Bloom, J., Anand, R., Veach, J., A randomised trial evaluating the efficacy and safety of ENA 713 ( Rivastigmine tartrate ), a new acetylcholinesterase inhibitor , in patients with mild to moderately severe Alzheimer’s disease. International Journal of Geriatric Psychopharmacology. 1998 ; 1 : 55-65. Curtis-prior, P., Vere, D., Fray, P., Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function., Journal of Pharmacy and pharmacology., 1999 ; 51 : 535-541. Dyer, A.M., Khan, K.A. and Aulton, M.E., Effect of the drying method on the mechanical and drug release properties of pellets prepared by extrusion-spheronization. Drug Development and Industrial Pharmacy., 1994 ; 20 : 30453068. Ford, J.L., Rubinstein, M.H. and Hogan J.E., Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl — methylcellulose matrices. International Journal of Pharmaceutics., 1985 ; 24 : 327-338. Goskonda, S.R., Hileman, G.A. and Upadrashta, S.M., Controlled release pellets by extrusion-spheronization. International Journal of Pharmaceutics., 1994 ; 111 : 89-97. Hachinski, V., Pryse-Phillips, W., Gauthier, S., Treatment of Alzheimer’s disease., Archive Neurology., 1999 ; 56 : 735-739. Hallen, L., Yliruusi, J., Process variables of instant granulators and spheroniser : II. Shape surface and distributions of pellets. International Journal of Pharmaceutics., 1993 ; 96 : 217-223. Hallen, L., Yliruusi, J., Merkku, P. and Kristofferson, E., Process variables of the radial screen extruder : III. Shape, surface, and flow properties of pellets. Pharm. Tech. Int., 1993d; 5 : 38-48. Hartman, D., Free radical theory of aging : Alzheimer’s disease pathogenesis. Age., 1995 ; 18 : 97-119. Hasznos, L., Langer, I. and Gyarmathy, M., Some factors influencing pellet characteristics made by an extrusion / spheronization process part I. : effects on size characteristics and moisture content decrease of pellets. Drug Development and Industrial Pharmacy., 1992 ; 18 : 409-437. Hong, J.E., Hydroxypropylmethylcellulose sustained release technology. Drug Development and Industrial Pharmacy., 1989 ; 15 : 975-999. Kader, A. and Jalil, R., Effect of physicochemical factors on the release kinetics of hydrophilic drugs from poly(L-Lactic acid)(L-PLA)pellets. Drug Development and Industrial Pharmacy., 1998 ; 24 : 535-539. Khatchaturian, Z.S., Diagnosis of Alzheimer’s disease. Archive Neurology. 1985 ; 42 : 1097-1105. Lee, P.I., Kinetics of drug release form hydrogel matrics. Journal of Controlled release., 1985 ; 2 : 277-288. Lieberman, H.A., Lachman, L. and Schwartz, J.B., Pharmaceutical Dosage Forms : Tablets., Marcel Dekker, INC., N. Y., 1989 : 195-245. Long, D.M. Aging in the nervous system. Neurosurgery., 1985 ; 17 : 348-354. Lucy, S.C., Wan, Paul, W.S., Heng and Celine, V., Spheronization conditions on spheroid shape and size. International Journal of Pharmaceutics., 1993 ; 96 : 59-65. Isaac G.S., Pharmaceutical pelletization Technology. Marcel dekker, Inc., 1989 : pp187-215 Montgomery, D.C., Design and Analysis of Experiments. 5th ed. Canada :John Wiley & Sons, Inc., 2001 : pp218-233 Otsuka, M., Gao, J. and Mastuda,Y., Effect of amount of added water during extrusion-spheronization process on pharmaceutical properties of granules. Drug Development and Industrial Pharmacy., 1994; 20(19) : 2977-2992. Perry, E.K., Pickering, A.T., Wang, W.W., Houghton, P. T., Perry, N. L., Medicinal plants and Alzheimer’s disease : From ethnobotany to Phytotherapy., Journal of Pharmacy and pharmacology., 1999 ; 51 : 527-534. Pillay, V. and Fassihi, R., Evalution and comparison of dissolution dataderived form different modified release dosage form: an alternative method. Journal of Controlled release., 1998 ; 55 : 45-55. Reekum, R.V., Simard, M. Farcnik, K., Diagnosis of dementia and treatment of Alzheimer’s disease., Candian Family Physician., 1999 ; 45 : 945-952. Regnstrom, J., Nilsson, J., Torn, vall. P.,Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis. Lancet. 1992 ; 339:1183-1186. Renoux, R., Demazieres, J.A., Cardot, J.M. and Aiache, J.M., Experimentally designed optimization direct compression tablets. Drug Development and Industrial Pharmacy., 1996 ; 22 : 103-109. Richter, C., Oxidative damage to mitochomdrial DNA and its relationship to aging. Int. J. Biochem. Cell. Biol. 1995 ; 27: 647-653. Robert, L. Aging of the vascular wall and atherogenesis : role of the elastin-laminin receptor., Atherosclerosis., 1996 ; 123 : 169-179. Sako, K., Nakashima, H., Sawada, T. and Frukui, M., Relationship between gelation rate of controlled-release acetaminophen tablets colonic drug release in dogs. Pharmaceutical Research., 1996 ; 13 : 594-599. Sano, M., Ernesto, C., Thomas, R. G., A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. New England Journal Medicine., 1997 ; 336 : 1216-1222. Schoenberg, M.H., Beger, H.G. Oxygen radicals in intestinal ischemia and reperfusion. Chemical Biology Interaction., 1990 ; 76: 141-161. Sienkiewicz, G., Pereira, R. Rudnic, E.M., Lausier, J.M. and Rhodes, C.T., Spheronization of theophylline-Avicel combinations using a fluidized-bed granulation technique. Drug Development and Industrial Pharmacy., 1997 ; 23 : 173-182. Sonaglio, D., Bataille, B., Ortigosa, C. and Jacob, M., Factorial design in the feasibility of producing Microcel MC101 pellets by extrusion-spheronization. International Journal of Pharmaceutics., 1995 ; 115 : 53-60. Tapia, C., Buckton, G. and Newton, J.M., Factors influencing the mechanism of release from sustained release matrix pellet, produced by extrusion-spheronization. International Journal of Pharmaceutics., 1993 ; 92 : 211-218. Torrado-Duran, J. J., Torrado S., Cadorniga R. and Augsburger L.L., Tableting Characteristics of Micro-aggregated Egg Albumin Particles Containing Paracetamol. Journal of Pharmacy Pharmacology., 1995 ; 47 : 115-119. Vertaet, C. and Baert, L., Risha, P.A. and Remon, J.P., The influence of the extrusion screen on pellet quality using an instrumented basket extruder. International Journal of Pharmaceutics., 1994 ; 107 : 29-39. Vuillaume, M., Reduced oxygen species, mutation, induction and cancer initiation. Mutation Reseach. 1987 ; 186 : 43-72. Wan, L., S. C., Heng, P. W. S. and Lien, C.V., Spheronization conditions on spheroid shape and size. International Journal of Pharmaceutics., 1993 ; 96 : 59-65. Wan, L. S. C., Heng, P. W. S. and Wong, L. F., Matrix Swelling : A simple model describing extent of swelling of HPMC matrices. International Journal of Pharmaceutics., 1995 ; 116 : 159-168. Wilson, C.G. and Washington, N., Physiological pharmaceutics : Biological Barriers to Drug Absorption, Ellis Horwood, Chichester, 1989 ; 60-70. Woodruff, C. W. and Nuessle, N. O., Effect of processing variables on particles obtained by extrusion-spheronization processing. Jornal Pharmaceutical Science., 1972 ; 61 : 787-790. Xie Ming., Modern study of the medical formula in traditional Chinese medicine. 1997 ; Vol.1 : 701-721(六味地黃丸). Younkin, S.M., Tanzi, R.E., Christen, Y., Presenilins and Alzheimer’s disease. Heidelberg, Germany : Springer-Verlag, 1998. Zheng Hu-zhan, Dong Ze-hong, She Jing., Modern study of traditional Chinese medicine. 1997 ; Vol.1 : 562-574(山藥). Zheng Hu-zhan, Dong Ze-hong, She Jing., Modern study of traditional Chinese medicine. 1997 ; Vol.1 : 574-591(山茱萸). Zheng Hu-zhan, Dong Ze-hong, She Jing., Modern study of traditional Chinese medicine. 1997 ; Vol.4 : 3022-3033(澤瀉). Zheng Hu-zhan, Dong Ze-hong, She Jing., Modern study of traditional Chinese medicine. 1997 ; Vol.4 : 3114-3137(茯苓). Zheng Hu-zhan, Dong Ze-hong, She Jing., Modern study of traditional Chinese medicine. 1997 ; Vol.3 : 2369-2395(牡丹皮). Zheng Hu-zhan, Dong Ze-hong, She Jing., Modern study of traditional Chinese medicine. 1997 ; Vol.2 : 1223-1265(熟地黃). 沈明來,試驗設計學,眾光,86年p175-211;p341-353 謝明村, 六味地黃丸增強學習記憶能力之藥理學研究,中國醫藥學 院,中醫藥委員會年報:1999;399-430 李時珍,本草綱目,國立中國醫藥研究所,65年p496;781;958;1196
|